手术治疗是肝细胞肝癌(HCC)的首选治疗方法。现代外科和围手术期技术的发展使肝硬化肝癌患者的手术并发症发生率及死亡率均明显下降,手术后5年的生存期已达35%。但由于肝癌常为多发性及80%的患者伴有严重的肝硬化,使HCC患者的手术切除率仅为20%左右,而且手术后肿瘤的复发率近70 Surgical treatment is the preferred treatment for hepatocellular carcinoma (HCC). The development of modern surgical and perioperative techniques has resulted in a significant reduction in the incidence of surgical complications and mortality in patients with cirrhosis of liver cancer, and the survival period of 5 years after surgery has reached 35%. However, because liver cancer is often multiple and 80% of patients with severe cirrhosis, the surgical resection rate of HCC patients is only about 20%, and the recurrence rate of tumors after surgery is nearly 70.